Alert: New Earnings Report (11/6/23)-Fennec Pharmaceuticals Inc (NASDAQ: FENC).
Fennec Pharmaceuticals Inc (NASDAQ: FENC) has reported E.P.S. of $-0.07 for its third fiscal quarter (ending September 30) versus $-0.31 for the same period a year ago. Relative to the consensus estimate of $-0.12, this […]